Skip to main content
 

orphan drug

Results 1 - 1 of 1Sort Results By: Published Date | Title | Company Name
Published By: G+     Published Date: May 17, 2011
Gerson Lehrman Group Inc.'s panel of experts discusses the commercial, clinical, and regulatory challenges unique to orphan drug development.
Tags : 
gerson lehrman group, orphan drug, regulatory challenges, drug development, commercialization, clinical
    
G+
Search      

Add Research

Get your company's research in the hands of targeted business professionals.